» Articles » PMID: 16153840

Structure-activity Relationship Study of Novel Necroptosis Inhibitors

Overview
Specialty Biochemistry
Date 2005 Sep 13
PMID 16153840
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Necroptosis is a regulated caspase-independent cell death mechanism that results in morphological features resembling necrosis. It can be induced in a FADD-deficient variant of human Jurkat T cells treated with TNF-alpha. 5-(1H-Indol-3-ylmethyl)-2-thiohydantoins and 5-(1H-indol-3-ylmethyl)hydantoins were found to be potent necroptosis inhibitors (called necrostatins). A SAR study revealed that several positions of the indole were intolerant of substitution, while small substituents at the 7-position resulted in increased inhibitory activity. The hydantoin ring was also quite sensitive to structural modifications. A representative member of this compound class demonstrated moderate pharmacokinetic characteristics and readily entered the central nervous system upon intravenous administration.

Citing Articles

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection.

Silva-Llanes I, Madruga E, Martinez A, Lastres-Becker I Front Neurosci. 2025; 18:1530809.

PMID: 39931431 PMC: 11808139. DOI: 10.3389/fnins.2024.1530809.


Forms of Non-Apoptotic Cell Death and Their Role in Gliomas-Presentation of the Current State of Knowledge.

Nafe R, Hattingen E Biomedicines. 2024; 12(7).

PMID: 39062119 PMC: 11274595. DOI: 10.3390/biomedicines12071546.


HSPA8 inhibitors augment cancer chemotherapeutic effectiveness via potentiating necroptosis.

Wu E, Wu C, Jia K, Zhou S, Sun L Mol Biol Cell. 2024; 35(8):ar108.

PMID: 38959101 PMC: 11321035. DOI: 10.1091/mbc.E24-04-0194.


Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease.

Bai P, Lan Y, Liu Y, Mondal P, Gomm A, Xu Y Adv Sci (Weinh). 2024; 11(32):e2309021.

PMID: 38923244 PMC: 11348174. DOI: 10.1002/advs.202309021.


Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms.

Sheng Y, Hu W, Chen S, Zhu X Front Immunol. 2024; 15:1275203.

PMID: 38779685 PMC: 11109379. DOI: 10.3389/fimmu.2024.1275203.